116 related articles for article (PubMed ID: 11451628)
21. Effect of various formulation variables on the encapsulation and stability of dibucaine base in multilamellar vesicles.
Nounou MM; El-Khordagui LK; Khalafallah N
Acta Pol Pharm; 2005; 62(5):369-79. PubMed ID: 16459486
[TBL] [Abstract][Full Text] [Related]
22. A novel approach to the pulmonary delivery of liposomes in dry powder form to eliminate the deleterious effects of milling.
Desai TR; Wong JP; Hancock RE; Finlay WH
J Pharm Sci; 2002 Feb; 91(2):482-91. PubMed ID: 11835207
[TBL] [Abstract][Full Text] [Related]
23. Effect of lyophilization on liposomal encapsulation of salmon calcitonin.
Swaminathan J; Ehrhardt C
J Liposome Res; 2014 Dec; 24(4):297-303. PubMed ID: 24708057
[TBL] [Abstract][Full Text] [Related]
24. [Development of Inhalable Dry Powder Formulations Loaded with Nanoparticles Maintaining Their Original Physical Properties and Functions].
Okuda T
Yakugaku Zasshi; 2017; 137(11):1339-1348. PubMed ID: 29093369
[TBL] [Abstract][Full Text] [Related]
25. Effects of formulation and operating variables on zanamivir dry powder inhalation characteristics and aerosolization performance.
Yang Y; Yang Z; Ren Y; Mei X
Drug Deliv; 2014 Sep; 21(6):480-6. PubMed ID: 24491208
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetic/pulmokinetic analysis of optimized lung targeted spray dried ketotifen-dextran core shell nanocomplexes-in-microparticles.
El Baihary D; Osman R; Abdel-Bar HM; Sammour OA
Int J Biol Macromol; 2019 Oct; 139():678-687. PubMed ID: 31381926
[TBL] [Abstract][Full Text] [Related]
27. Preparation and characterization of lysozyme loaded liposomal dry powder inhalation using non-ionic surfactants.
Lee JJ; Dinh L; Park J; Khraisat R; Park JW; Jeong JK; Lee J; Kim HS; Park MS; Ahn JH; Hwang SJ
Int J Pharm; 2023 Nov; 646():123426. PubMed ID: 37729976
[TBL] [Abstract][Full Text] [Related]
28. Proliposome Powders for the Generation of Liposomes: the Influence of Carbohydrate Carrier and Separation Conditions on Crystallinity and Entrapment of a Model Antiasthma Steroid.
Khan I; Yousaf S; Subramanian S; Alhnan MA; Ahmed W; Elhissi A
AAPS PharmSciTech; 2018 Jan; 19(1):262-274. PubMed ID: 28698930
[TBL] [Abstract][Full Text] [Related]
29. Preparation, characterization, and in vivo evaluation of intranasally administered liposomal formulation of donepezil.
Al Asmari AK; Ullah Z; Tariq M; Fatani A
Drug Des Devel Ther; 2016; 10():205-15. PubMed ID: 26834457
[TBL] [Abstract][Full Text] [Related]
30. Development of a child-friendly oral drug formulation using liposomal multilamellar vesicle technology.
Al Fayez N; Böttger R; Ghosh S; Nakajima Y; Chao PH; Rouhollahi E; Nguyen A; Cullis PR; Witzigmann D; Li SD
Int J Pharm; 2022 Sep; 625():122107. PubMed ID: 35964828
[TBL] [Abstract][Full Text] [Related]
31. Development of vitamin loaded topical liposomal formulation using factorial design approach: drug deposition and stability.
Padamwar MN; Pokharkar VB
Int J Pharm; 2006 Aug; 320(1-2):37-44. PubMed ID: 16707237
[TBL] [Abstract][Full Text] [Related]
32. Proliposome powders prepared using a slurry method for the generation of beclometasone dipropionate liposomes.
Khan I; Yousaf S; Subramanian S; Korale O; Alhnan MA; Ahmed W; Taylor KM; Elhissi A
Int J Pharm; 2015 Dec; 496(2):342-50. PubMed ID: 26456265
[TBL] [Abstract][Full Text] [Related]
33. Drug-fortified liposomes as carriers for sustained release of NSAIDs: The concept and its validation in the animal model for the treatment of arthritis.
Pawar VA; Manjappa AS; Murumkar PR; Gajaria TK; Devkar RV; Mishra AK; Yadav MR
Eur J Pharm Sci; 2018 Dec; 125():11-22. PubMed ID: 30219410
[TBL] [Abstract][Full Text] [Related]
34. Preparation, optimization, and in vitro simulated inhalation delivery of carvedilol nanoparticles loaded on a coarse carrier intended for pulmonary administration.
Abdelbary AA; Al-mahallawi AM; Abdelrahim ME; Ali AM
Int J Nanomedicine; 2015; 10():6339-53. PubMed ID: 26491298
[TBL] [Abstract][Full Text] [Related]
35. The effects of lyophilization on the stability of liposomes containing 5-FU.
Glavas-Dodov M; Fredro-Kumbaradzi E; Goracinova K; Simonoska M; Calis S; Trajkovic-Jolevska S; Hincal AA
Int J Pharm; 2005 Mar; 291(1-2):79-86. PubMed ID: 15707734
[TBL] [Abstract][Full Text] [Related]
36. PEGylated Liposomes of Meloxicam: Optimization by Quality by Design, in vitro Characterization and Cytotoxicity Evaluation.
Shaji J; Menon I
Pharm Nanotechnol; 2017; 5(2):119-137. PubMed ID: 28462699
[TBL] [Abstract][Full Text] [Related]
37. Novel delivery approach for ketotifen fumarate: dissofilms formulation using 3² experimental design: in vitro/in vivo evaluation.
Fahmy RH; Badr-Eldin SM
Pharm Dev Technol; 2014 Aug; 19(5):521-30. PubMed ID: 23713715
[TBL] [Abstract][Full Text] [Related]
38. In vitro deposition of the respirable fraction of dry powder inhalations determined by laser diffractometry and inertial impaction.
Marques HM; Schmidt PC
Pharmazie; 2002 Aug; 57(8):546-51. PubMed ID: 12227195
[TBL] [Abstract][Full Text] [Related]
39. Formulation of novel dry powder inhalation for fluticasone propionate and salmeterol xinafoate with capsule-based device.
Kim KS; Kim JH; Jin SG; Kim DW; Kim JO; Yong CS; Youn YS; Oh KT; Woo JS; Choi HG
Pharm Dev Technol; 2018 Feb; 23(2):158-166. PubMed ID: 28612675
[TBL] [Abstract][Full Text] [Related]
40. Preparation, optimization, characterization, and stability studies of salicylic acid liposomes.
Bhalerao SS; Raje Harshal A
Drug Dev Ind Pharm; 2003 Apr; 29(4):451-67. PubMed ID: 12737538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
